EUVIMEDOpdag EUVIMED
Open access

In Silico Discovery of Potential Inhibitors Targeting the MEIG1 ‐ PACRG Complex for Male Contraceptive Development

Timothy Hasse iD, Zhibing Zhang, Yu-Ming M Huang iD

Proteins: Structure, Function, and Bioinformatics · 2025

DOI: 10.1002/prot.26829 ↗

At a glance

Journal article in Proteins: Structure, Function, and Bioinformatics, 2025. Written by Timothy Hasse and 2 co-authors. Institution: Department of Physics and Astronomy, Wayne State University, Detroit, Michigan, USA. Major MEDLINE topics: Contraceptive Agents, Male, Cell Cycle Proteins, Small Molecule Libraries, Nuclear Proteins. 38 references. The full text is freely available in PubMed Central. Funded by: NIH HHS, NICHD NIH HHS, Wayne State University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The interaction between meiosis‐expressed gene 1 (MEIG1) and Parkin co‐regulated gene (PACRG) is a critical determinant of spermiogenesis, the process by which round spermatids mature into functional spermatozoa. Disruption of the MEIG1‐PACRG complex can impair sperm development, highlighting its potential as a therapeutic target for addressing male infertility or for the development of non‐hormonal contraceptive methods. This study used virtual screening, molecular docking, and molecular dynamics (MD) simulations to identify small molecule inhibitors targeting the MEIG1‐PACRG interface. MD simulations provided representative protein conformations, which were used to virtually screen a library of 821 438 compounds, resulting in 48 high‐ranking candidates for each protein. PACRG emerged as a favorable target due to its flexible binding pockets and better docking scores compared to MEIG1. Key binding residues with compounds included W50, Y68, N70, and E74 on MEIG1, and K93, W96, E101, and H137 on PACRG. MD simulations revealed that compound stability in MEIG1 complexes is primarily maintained by hydrogen bonding with E74 and π‐π stacking interactions with W50 and Y68. In PACRG complexes, compound stabilization is facilitated by hydrogen bonding with E101 and π‐π interactions involving W96 and H137. These findings highlight distinct molecular determinants of ligand binding for each protein. Our work provides mechanistic insights and identifies promising compounds for further experimental validation, establishing a foundation for developing MEIG1‐PACRG interaction inhibitors as male contraceptives.

Subjects

MeSH terms (MEDLINE)

Contraceptive Agents, MaleCell Cycle ProteinsSmall Molecule LibrariesNuclear ProteinsUbiquitin-Protein LigasesMolecular Docking SimulationMaleHumansMolecular Dynamics SimulationProtein BindingBinding SitesDrug Discovery

Author keywords

computational drug designnon‐hormonal contraceptivesreproductive biologysmall molecule screeningstructure‐based drug discovery

Substances

Contraceptive Agents, MaleCell Cycle ProteinsSmall Molecule LibrariesNuclear ProteinsUbiquitin-Protein Ligases

Authors and institutions

  • Department of Physics and Astronomy, Wayne State University, Detroit, Michigan, USA.
  • Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA.

ORCID profiles: Timothy Hasse, Yu-Ming M Huang

Funding

  • NIH HHS
  • NICHD NIH HHS
  • Wayne State University
  • National Institutes of Health

Cite

APA

Hasse, T., Zhang, Z., & Huang, Y. M. (2025). In Silico Discovery of Potential Inhibitors Targeting the MEIG1 ‐ PACRG Complex for Male Contraceptive Development. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26829

Vancouver

Hasse T, Zhang Z, Huang YM. In Silico Discovery of Potential Inhibitors Targeting the MEIG1 ‐ PACRG Complex for Male Contraceptive Development. Proteins: Structure, Function, and Bioinformatics. 2025. doi:10.1002/prot.26829

BibTeX
@article{Hasse2025,
  author = {Hasse, Timothy and Zhang, Zhibing and Huang, Yu-Ming M},
  title = {In Silico Discovery of Potential Inhibitors Targeting the MEIG1 ‐ PACRG Complex for Male Contraceptive Development},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2025},
  doi = {10.1002/prot.26829}
}
Start for free →